Prognostic subgroups for citalopram response in the STAR*D trial.

@article{Jakubovski2014PrognosticSF,
  title={Prognostic subgroups for citalopram response in the STAR*D trial.},
  author={Ewgeni Jakubovski and Michael H Bloch},
  journal={The Journal of clinical psychiatry},
  year={2014},
  volume={75 7},
  pages={738-47}
}
OBJECTIVE Few data exist to help clinicians predict likelihood of treatment response in individual patients with major depressive disorder (MDD). Our aim was to identify subgroups of MDD patients with differential treatment outcomes based on presenting clinical characteristics. We also sought to quantify the likelihood of treatment success based on the degree of improvement and side effects after 2 and 4 weeks of selective serotonin reuptake inhibitor (SSRI) pharmacotherapy. METHOD We… CONTINUE READING